CD4 and systemic lupus erythematosus: In vitro, IFN-I were shown to prolong survival of CD4+ T cells [33], and in a non-lupus model, IFN-I enhanced the clonal expansion of antigen-specific CD4+ T cells by increasing survival signals and leading to increased numbers of IFNγ producing cells [34].